Clinical Trial Update: A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of food on the pharmacokinetics of lumacaftor when combined with ivacaftor in cystic fibrosis; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ORKAMBI (lumacaftor and ivacaftor)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED